Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?
作者信息
Karer Matthias, Stiasny Karin, Zeitlinger Markus, Jilma Bernd
机构信息
Department of Clinical Pharmacology.
Center for Virology, Medical University of Vienna, Vienna, Austria.
出版信息
Blood Coagul Fibrinolysis. 2021 Sep 1;32(6):423-424. doi: 10.1097/MBC.0000000000001048.
Abstract
摘要
相似文献
1
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?皮下注射针对严重急性呼吸综合征冠状病毒2的mRNA疫苗：重症出血性疾病患者或抗凝治疗患者的一种选择？
Blood Coagul Fibrinolysis. 2021 Sep 1;32(6):423-424. doi: 10.1097/MBC.0000000000001048.
2
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.一种雾化型腺病毒 5 型载体新冠疫苗（Ad5-nCoV）在成年人中的安全性、耐受性和免疫原性：一项开放标签、随机 1 期临床试验的初步报告。
Lancet Infect Dis. 2021 Dec;21(12):1654-1664. doi: 10.1016/S1473-3099(21)00396-0. Epub 2021 Jul 26.
3
Homologous and Heterologous Covid-19 Booster Vaccinations.同源和异源 COVID-19 加强针接种。
N Engl J Med. 2022 Mar 17;386(11):1046-1057. doi: 10.1056/NEJMoa2116414. Epub 2022 Jan 26.
4
Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎疫苗的有效性、免疫原性和安全性的系统评价和荟萃分析。
Front Immunol. 2021 Oct 11;12:714170. doi: 10.3389/fimmu.2021.714170. eCollection 2021.
5
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.《 老年人中新型冠状病毒 mRNA-1273 疫苗的安全性和免疫原性》
N Engl J Med. 2020 Dec 17;383(25):2427-2438. doi: 10.1056/NEJMoa2028436. Epub 2020 Sep 29.
6
Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.骨髓瘤老年患者在接种第一剂BNT162b2疫苗后对新冠病毒的中和抗体反应较低。
Blood. 2021 Jul 1;137(26):3674-3676. doi: 10.1182/blood.2021011904.
7
Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?接受BNT162b2 mRNA疫苗或AZD1222疫苗的健康志愿者中针对SARS-CoV-2的中和抗体反应比较：AZD1222疫苗的第二剂是否应提前接种？
Am J Hematol. 2021 Sep 1;96(9):E321-E324. doi: 10.1002/ajh.26248. Epub 2021 Jun 2.
8
The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2.接种BNT162b2疫苗后不同血液系统癌症中抗SARS-CoV-2抗体的12周动力学
Br J Haematol. 2022 Jan;196(2):362-367. doi: 10.1111/bjh.17821. Epub 2021 Sep 6.
9
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.由 BNT162b2 mRNA 疫苗诱导的人血清对 SARS-CoV-2 奥密克戎的中和作用。
Science. 2022 Feb 11;375(6581):678-680. doi: 10.1126/science.abn7591. Epub 2022 Jan 18.
10
SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.SARS-CoV-2 mRNA 疫苗在免疫原性初免和预免疫人群中引发不同的反应。
Front Immunol. 2021 Sep 27;12:728021. doi: 10.3389/fimmu.2021.728021. eCollection 2021.
引用本文的文献
1
Association of the immunogenicity of intramuscular SARS-CoV-2 mRNA vaccination with computed tomography muscle images in patients with muscular disorders.肌肉疾病患者中，肌肉注射严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗的免疫原性与计算机断层扫描肌肉图像的关联
Front Immunol. 2024 Dec 20;15:1479321. doi: 10.3389/fimmu.2024.1479321. eCollection 2024.
2
Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review.信使核糖核酸（mRNA）疫苗及其递送系统的最新进展：综述
Clin Pharmacol. 2023 Aug 3;15:77-98. doi: 10.2147/CPAA.S418314. eCollection 2023.
3
mRNA vaccines in the prevention and treatment of diseases.信使核糖核酸疫苗在疾病预防和治疗中的应用
MedComm (2020). 2022 Aug 25;3(3):e167. doi: 10.1002/mco2.167. eCollection 2022 Sep.
4
Safety of intramuscular COVID-19 vaccination in patients with haemophilia.肌内 COVID-19 疫苗接种在血友病患者中的安全性。
Haemophilia. 2022 Sep;28(5):687-693. doi: 10.1111/hae.14586. Epub 2022 May 13.
Zotero 插件